Commonwealth Biotechnologies, Inc. - Senior Scientific Staff [text]

Staff
-Corporate Officers
-Senior Scientists
-Human Resources

Marketing
-Staff
-Quote Request
-Literature Request

Investor Info
-Annual Report

DNA Sequencing
-DNA Sequencing
-Genome Sequencing
-Computer-based
Homology Searches

Nucleic Acid Synthesis
-DNA/RNA/PNA Synthesis
-Gene Synthesis

Peptide Technologies
-Peptide Synthesis
-Amino Acid Synthesis
-Peptide Sequencing

Protein Technologies
-Protein (N- and C- Terminal) Sequencing
-Monoclonal & Polyclonal Antibodies
-Purification
-Overexpression Projects
-Peptide Mapping
-Computer-based homology searches

Molecular Biology
-Plasmid Preparation
-Cloning & Overexpression Projects
-Site-directed Mutagenesis
-Genomic or cDNA Libraries
-Library Screening
-Northern or Southern Blot Analysis
-Computer Based Homology Searches

Genetic Testing Services
-Human Genetic Analysis
-Veterinary Genetic Analysis
-DNA Identity testing (CODIS Databasing)
-DNA Fingerprinting

Biophysical Analysis
-Mass Spectrometry
-Calorimetry

Text Home Page
Graphics Version

Senior Scientific Staff

Russell L. Wolz, Ph.D.
Dr. Wolz joined the Company in August, 1996, as Senior Research Scientist. Wolz heads the Company's biochemistry research services. Until 1996, Wolz was Assistant Professor at Indiana University of Pennsylvania, and was previously an Assistant Professor in the Department of Biochemistry and Molecular Biology at the Penn State University College of Medicine, Hershey, PA. Dr. Wolz received a Bachelor's degree in Chemistry from Colorado State University, and the Doctoral degree from Northwestern University, in Biochemistry. Wolz is the co-author of more than 15 peer reviewed journal articles and book chapters in the general areas of his research expertise, protein structure and function. Wolz is credited with co-discovery of the zinc binding motif common to all zinc-metallo proteinases. Wolz is the Principal Investigator on Phase I and Phase II Small Business Innovative Research Awards issued to the Company from the NIH and USDA, respectively.

Luis Shozo Ozaki, Ph.D.
Dr. Ozaki joined the Company in August, 1997, as Senior Research Scientist. Ozaki heads the Company's genetic identity research services and is charged with performance of long-term molecular biology projects. From 1988- 1997, Ozaki was an Associate Professor of Molecular Biology at the Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, but during this period, he also spent time as an Adjunct Faculty member at Washington State University, Pullman, and WA. Dr. Ozaki received the Bachelor's and M.S. degrees in Biology and Molecular Biology, respectively, from the University of Brasilia, Brasilia, Brazil, and the Doctoral degree from the University of Kyushu, Fukuoka, Japan, in Molecular Biology. Ozaki is the co-author of more than 30 peer reviewed journal articles and book chapters in the general areas of his research expertise, parasitology and molecular biology, and is the co-inventor of European and Brazilian patents.

Natesa Muthukumaraswamy, Ph.D.
Dr."Swamy" joined the Company in January, 1997, as Senior Scientist. Prior to joining the Company Swamy was on the faculty of Virginia Commonwealth University, first in the Department of Pharmacology & Toxiocology (1977-1992) and then in the Department of Biomedical Engineering (1992-1997). Swamy is an integral member of the peptide synthesis group, and is expert in all phases of solid-phase and solution-phase chemical synthesis of peptides and peptide analogs. Swamy received the Bachelor's and Masters degrees in Chemistry from Madras University, Madras, India, and the Doctoral degree in Organic Chemistry from the same institution. He is the co-author of more than 30 peer reviewed journal articles and book chapters.

Darin R. Kent, Ph.D.
Dr. Kent joined the Company in October, 1997, as Research Scientist, and heads the Company's bioorganic research services. Until 1997, Kent was employed at Parke Davis Pharmaceutical Research Center, a Division of the Warner Lambert Company. Dr. Kent received a Bachelor's degree in Biochemistry (Cum Laude) from the California State University, San Francisco, and the Doctoral degree from the University of California at San Diego, in Organic Chemistry. Kent is the co- author of 10 peer reviewed journal articles in the general areas of his research expertise, asymmetric synthesis and peptidomimetics.

Robert E. Langford, B.S.
Mr. Langford joined the Company in December, 1997, as Senior Information Technology Analyst and Administrator. Until 1997, Langford was employed as a systems analyst at Virginia Commonwealth University. Langford received the Bachelor's degree in Mathematics from VCU in 1983.

Kristen R. Kralovich, M.S.
Ms. Kralovich joined the Company in June, 1998, as Senior Laboratory Specialist and is the Laboratory Coordinator for Protein/Peptide Chemistries. Kralovich received a Bachelor's degree in Molecular and Cell Biology from the Pennsylvania State University, College Park, and the Master of Science degree in Biochemistry and Molecular Genetics from the University of Virginia, Charlottesville. Kralovich is the co-author of peer reviewed journal articles in the general areas of her research expertise, cell culture and receptor mediated events.

Douglas R. Oliveri, PhD, FACMG.
Dr. Oliveri joined the Company in February, 1999, as Director of Human Genetics and Genetic Analysis. From 1995-1999, he served as Director of the DNA Laboratory at Applied Genetics in Austin, TX. From 1992-1995, he served as assistant professor of pathology and human genetics at the University of Pittsburgh and as a full member of the Pittsburgh Cancer Institute. Dr. Oliveri holds certifications in Clinical Molecular Genetics and Clinical Biochemical Genetics by the American Board of Medical Genetics. He received his Bachelor's degree in Biology from St. Louis University, Doctoral degree in Genetics from the University of California, Davis, and Post Graduate Human Genetics Training from the University of Chicago.

Commonwealth Biotechnologies, Inc.
601 Biotech Drive, Richmond, VA 23235
800-735-9224 / FAX: 804-648-2461
Toll-Free FAX on Demand: (877) FAX-4-CBI
email: [email protected]